TNFRSF8 and lymphoma: Savoldo’s group showed that CD30 CAR-T cells co-expressing CCR4 (CCR4.CD30.CAR-T cells) exhibited improved tumor homing and anti-lymphoma activity compared to CD30 CAR-T cells lacking CCR4 expression [64].